What Whitehawk Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 14 |
| Total trades | 0 | 26 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 3,334,312 |
| Disposed | 0 | 705,358 |
| Net activity | +0 | +2,628,954 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | May 14 | Grant / award · A | +38,265 | $3.92 | +$150K | 333,489 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | May 14 | Grant / award · A | +51,021 | $3.92 | +$200K | 569,643 |
| Ball Bryan | See remarks | May 14 | Grant / award · A | +51,020 | $3.92 | +$200K | 448,126 |
| Dalal Anupam | Director | May 14 | Grant / award · A | +1,275,510 | $3.92 | +$5M | 4,685,912 |
| Castelein Caley | Director | May 14 | Grant / award · A | +255,102 | $3.92 | +$1M | 274,796 |
| Dugan Margaret | Chief Medical Officer | May 14 | Grant / award · A | +19,132 | $3.92 | +$75K | 19,132 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 16 | Open-market sale · S | −141,600 | $4.13 | −$585K | 295,224 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 15 | Open-market sale · S | −77,000 | $3.86 | −$297K | 436,824 |
| Ball Bryan | See remarks | Apr 14 | Open-market sale · S | −92,460 | $3.64 | −$337K | 397,106 |
| Ball Bryan | See remarks | Apr 13 | Open-market sale · S | −26,389 | $3.46 | −$91.3K | 489,566 |
| Ball Bryan | See remarks | Apr 10 | Open-market sale · S | −6,596 | $3.43 | −$22.6K | 515,955 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | Apr 09 | Open-market sale · S | −14,500 | $3.38 | −$49K | 518,622 |
| Ball Bryan | See remarks | Apr 09 | Open-market sale · S | −50,000 | $3.57 | −$179K | 522,551 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | Apr 08 | Open-market sale · S | −63,945 | $3.40 | −$217K | 533,122 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | Apr 07 | Open-market sale · S | −94,087 | $3.43 | −$323K | 597,067 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | Apr 06 | Open-market sale · S | −102,395 | $3.51 | −$359K | 691,154 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | Apr 02 | Open-market sale · S | −26,858 | $3.48 | −$93.5K | 793,549 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 01 | Exercise / conversion · M | +473,902 | — | — | 502,002 |
| Ball Bryan | See remarks | Apr 01 | Exercise / conversion · M | +366,532 | — | — | 572,551 |
| Lennon David James | CHIEF EXECUTIVE OFFICER | Apr 01 | Exercise / conversion · M | +775,828 | — | — | 820,407 |
Loading...
